Draflazine

Overview

Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freund’s adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Adenosine Receptor | Products > Signaling Pathways > Nucleoside Transporters

Product Information

• Catalog No.: HY-106841
• CAS No.: 120770-34-5
• Molecular Formula: C30H33Cl2F2N5O2
• Molecular Weight: 604.52
• Purity: 99.06%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.14 mM); Clear solution
• Availability: In-stock

Source

Original product source